Navigation Links
Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine

e not only in diabetes, but also in several central nervous system-related diseases. Diamyd Medical has an exclusive world-wide license from the University of California at Los Angeles regarding the therapeutic use of the GAD65 gene.

Diamyd Medical has sublicensed its UCLA GAD65 Composition of Matter license to Neurologix, Inc. in Fort Lee, New Jersey for treatment of Parkinson’s disease with an AAV-vector.

Other projects comprise drug development within gene therapy using the exclusively licensed and patent protected Nerve Targeted Drug Delivery System (NTDDS). The company’s lead gene therapy projects include using Enkephalin and GAD for chronic pain, e.g., diabetes pain or cancer pain. All projects in this field are currently in preclinical phases.

Diamyd Medical has offices in Stockholm (Sweden) and in Pittsburgh (USA). The Diamyd Medical share is quoted on the Stockholm Nordic Exchange in Sweden (ticker symbol: DIAM B) and on the OTCQX-list in the US (ticker symbol: DMYDY) administered by the Pink Sheets and the Bank of New York (PAL). Further information is available at www.diamyd.com.



For further information, please contact:
Stockholm-office
Anders Essen-Möller
CEO and President
Tel: +46 8 661 0026
E-mail: investor.relations@diamyd.com

Pittsburgh office
Michael Christini
President
Tel: +1 412 770 1310
E-mail: Michael.Christini@diamyd.com

For media contact in the US, please contact:
Gregory Tiberend
Executive Vice President
Richard Lewis Communications, Inc.
Tel: +1 212 827 0020
E-mail: gtiberend@rlcinc.com

Diamyd Medical AB (publ). Linnégat
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mild Asthma, a Revolutionary Therapy from Italian Research
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
5. Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder
6. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
7. EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
8. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
9. Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinsons Patients
10. Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function
11. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality

Post Your Comments:
(Date:11/25/2009)... , CHAPEL HILL, N.C., Nov. 25 ...rabhavathi Fernandes, president and chief executiv...Annual Health Care Conference at 8:50 a.m. EST, De...w York City. Dr. Fernandes will provide an overvi...l programs for the treatment of drug-resistant pat...
(Date:11/25/2009)..., FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /PRNews...Nasdaq: HTWR ; ASX: HIN), a leading innovator and...ry support technologies revolutionizing the treatm...t it is scheduled to make an investor presentation...erence at 8:00 am EST on Wednesday, December 2, 20...
(Date:11/24/2009)..., IRVINE, Calif., Nov. 24 /PRNewswire-FirstCall/ ...minimally invasive treatments for aortic disorders...ay, or discontinue all proceedings in, the patent ... 2009 by Cook, Inc. The motion was filed in the U...na. ,, Endologix has requested that the stay re...
Breaking Medicine Technology:HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Hospital Workers May Trigger Dangerous Outbreaks 59765 1Hospital Workers May Trigger Dangerous Outbreaks 59765 2Hospital Workers May Trigger Dangerous Outbreaks 59765 3Pediatricians put proven treatment strategies to work against childhood asthma 59760 1Pediatricians put proven treatment strategies to work against childhood asthma 59760 2Global warming may spur increased growth in Pacific Northwest forests 10416 1Global warming may spur increased growth in Pacific Northwest forests 10416 2Global warming may spur increased growth in Pacific Northwest forests 10416 3
...AGEN donates one million tests to expand access to... , VENLO, Netherlands, April 1 Results from an e...published today in The New England Journal of Med...tings a single round of HPV testing significantly ...nd deaths, compared with Pap (cytology) testing or...
...NVER, April 1 Responding to President Obama,s cal...eutical Research and Manufacturers of America (PhR...he research pipeline for cancer. The report shows ...nology companies are testing a record 861 new canc... the report are being tested in human clinical tri...
Other Medicine Technology:Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap 2Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap 3Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap 4Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap 5New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 2New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 3New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 4
(Date:11/27/2009)...Newswire-FirstCall/ -- Shamir Optical Industry Ltd...r of innovative products and technology to the oph...d of directors had declared a dividend distributio...imately NIS 37.62 million based on the November 25...imately US$ 0.609 (approximately NIS 2.3 based on ...
(Date:11/27/2009)... announced today that Spectrum Health (Grand Rapid... orthopedic templating solution and its TraumaCad ... (PRWEB) November 27, 2009 -- Voyant Health&trad...ids, Michigan) has licensed its TraumaCad Enterpri...d Extend workflow solution, to allow its orthopedi...
(Date:11/26/2009)...wire/ -- The diabetes population in the United Sta...annual medical spending on the disease is projecte... according to a study published in the December is...abetes ® Program (NCDP), a program of Novo No...e University of Chicago. ,, According to the fo...
(Date:11/26/2009)... the North Pole, Textsanta.net lets parents sign u... North Pole, AK (PRWEB) -- In ...the North Pole Santa Claus has added SMS text mess...ormed of his Christmas progress at the North Pole....ve identified a large and growing percentage of Am...
(Date:11/25/2009)...USNewswire/ -- When most people hear the acronym T...or can also give patients the help they need. TMJ ... where your jaw (mandible) contacts/connects with ... symptoms associated with TMJ dysfunction are pain...t many other symptoms can be caused from TMJ dysfu...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...pt. 21 Cephalon, Inc. (Nasdaq:,CEPH) today announ...NDA) to,the U.S. Food and Drug Administration (FDA...HCl) for the treatment of patients with chronic,ly...ted States, according to the National Cancer Insti...
...he right grains for breakfast, such as whole-grain... is facilitated after breakfast, lunch, and dinner...rain products have this effect all day. This is du...esented in a dissertation from the Faculty of Engi...
... Sept. 14, 2007 -- A new study by researchers at t... some TV may be good for you. , Researchers foun...ama ER that dealt with teen obesity, hypertension .... 14 Journal of Health Communication and now avail...
...produce treatments to kill off cancer cells, exper...information about a process called unplanned cell ...t heart disease, cancer, stroke and other life-thr...death caused by outside factors, such as traumatic...
...., Sept. 21 Schering-Plough,Corporation (NYSE: S...gs,results for the 2007 third quarter on Monday, O...ng-Plough will conduct a conference,call to review...o listen live to the call, dial 1-877-565-9664 or ...
...Sept. 21 A sellout crowd will honor,Texas House S...t the 5th,Annual Speaker,s Golf Tournament, an eve...nt of money raised by last year,s tournament, with... event, proceeds from the tournament have snowball...
Other Medicine News:Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4Health News:Right breakfast bread keeps blood sugar in check all day 2Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Clues to Cell Death Could Fight Disease 2Health News:2007 Speaker's Golf Tournament Sets 5-Year Fundraising Record 2
Kratz-Barraquer Eye Speculum
Lehner Temporal Speculum
Wiener Eye Speculum
McKinney Eye Speculum
Medicine Products: